We further validated the role of DDX42 and GRB2 in cell proliferation, and radio‐ and sorafenib resistance in HCC cells via clonogenic, CCK‐8, and EdU assays, and identified their potential downstream PI3K/AKT signalling pathways. The gene discussed is GRB2; the disease is hepatocellular carcinoma.